Eurofins Expands Renal and Transplant Testing Offerings with Ascend Clinical Acquisition

Established in 2000, Ascend Clinical is the largest independent laboratory specializing in kidney dialysis testing in the U.S. Situated in Sunnyvale, California, Ascend boasts a state-of-the-art facility and a dedicated team of 170 professionals. The company provides advanced chemistry, hematology, microbiology, and virology testing services to dialysis clinics and hospitals nationwide. Additionally, Ascend offers essential water and dialysate testing services to ensure safety standards for dialysis patients and compliance with regulations.

This acquisition aligns perfectly with Eurofins’ dedication to delivering exceptional testing services in the renal and transplantation fields. By integrating Ascend’s expertise and clientele with Eurofins’ extensive laboratory network and analytical portfolio, both entities aim to elevate the standard of care provided to patients across the country.

Dr. Gilles Martin, CEO of Eurofins, expressed his excitement about the acquisition, stating, “This transaction expands our commitment to delivering top-notch testing services to patients in the renal and transplantation sectors. We eagerly anticipate offering Ascend’s clients access to the capabilities of the Eurofins network and supporting Ascend in enhancing and expanding their vital services for patients.”

Patti Hunsader, Ascend’s current COO, echoed Dr. Martin’s sentiments, highlighting the exciting opportunities arising from the partnership with Eurofins. “We are thrilled to join forces with the Eurofins network. This collaboration presents exciting prospects to leverage our combined expertise and resources to positively impact the lives of the patients we serve,” said Hunsader.

Under Patti Hunsader’s leadership, who will transition into the role of President of Ascend Clinical, the existing management team will continue to spearhead the organization’s growth within Eurofins’ clinical diagnostics business line in the United States.

Eurofins’ strategic expansion into renal and transplant testing underscores its commitment to delivering comprehensive and innovative solutions to meet the evolving needs of healthcare providers and patients across the globe.